MINJU KIM: Open Payments
NPI 1992073761 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 12 payments from 8 companies in 2025. Trend: 2023 $212 · 2024 $187 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 2 | $162 |
| SCPHARMACEUTICALS INC. | 2 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Aurinia Pharma U.S., Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $15 |
| Calliditas Therapeutics US Inc. | 1 | $14 |
Products named: FUROSCIX, JYNARQUE, LUPKYNIS, Vanrafia, JARDIANCE, IBSRELA, TARPEYO.
Industry payments across GA — which companies pay providers there.
